Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs

  • Posted on September 21, 2026
  • By CNBC
  • 0 Views
  • 1 min read
In brief

Generating AI summary…

Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs
Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs

Novo stock falls 7% despite $23 billion sales target for blockbuster obesity drugs continue reading...

Author
CNBC

You May Also Like